Challenges to the design and execution of controlled clinical studies of anticoagulants in patients with heparin-induced thrombocytopenia: lessons learned.
Citation: Journal of Thrombosis & Thrombolysis. 33(1):124-8, 2012 Jan.PMID: 21918906Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Heparin/ae [Adverse Effects] | *Research Design | *Thrombocytopenia/ci [Chemically Induced] | *Thrombocytopenia/pc [Prevention & Control] | Controlled Clinical Trials as Topic/mt [Methods] | Controlled Clinical Trials as Topic/td [Trends] | Humans | Randomized Controlled Trials as Topic/mt [Methods] | Randomized Controlled Trials as Topic/td [Trends] | Research Design/td [Trends]Year: 2012ISSN:- 0929-5305
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 21918906 | Available | 21918906 |
English